Tag Archives: JAPAN HEALTH PANEL APPROVES MERCK’S ORAL COVID-19 TREATMENT

A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck, part of Prime Minister Fumio Kishida’s plan to roll out new treatments by year-end as concerns rise about the Omicron variant. The panel’s decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier …

Read More »